Skip to content

Clinical trials

Phase 4 Glucose Intolerance trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glucose Intolerance Phase: Phase 4 Country / region: United States Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20041
20063
20074
20081
20091
20102
20113
20121
20131
20161
20182
20202
20211
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated6
Recruiting3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Carl T. Hayden VA Medical Center2
Ohio State University2
Stanford University2
The University of Texas Health Science Center at San Antonio2
Woman's2
Baylor College of Medicine1
Beth Israel Deaconess Medical Center1
Denver Research Institute1
Duke University1
Forest Laboratories1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glucose Intolerance28
Insulin Resistance9
Obesity7
Diabetes Mellitus, Type 25
Diabetes Mellitus3
Metabolic Syndrome3
Prediabetic State3
Hypertension2
Attention Deficit Disorder with Hyperactivity1
Cardiovascular Diseases1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.